These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8620426)

  • 1. A 15-year experience with chemotherapy of patients with paraganglioma.
    Patel SR; Winchester DJ; Benjamin RS
    Cancer; 1995 Oct; 76(8):1476-80. PubMed ID: 8620426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myxoid liposarcoma. Experience with chemotherapy.
    Patel SR; Burgess MA; Plager C; Papadopoulos NE; Linke KA; Benjamin RS
    Cancer; 1994 Aug; 74(4):1265-9. PubMed ID: 8055448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxoid malignant fibrous histiocytoma: experience with chemotherapy.
    Patel SR; Plager C; Papadopoulos NE; Benjamin RS
    Am J Clin Oncol; 1995 Dec; 18(6):528-31. PubMed ID: 8526198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas.
    Asai S; Katabami T; Tsuiki M; Tanaka Y; Naruse M
    Horm Cancer; 2017 Apr; 8(2):108-118. PubMed ID: 28108930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.
    Odunsi K; Moneke V; Tammela J; Ghamande S; Seago P; Driscoll D; Marchetti D; Baker T; Lele S
    Int J Gynecol Cancer; 2004; 14(4):659-64. PubMed ID: 15304162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraskeletal myxoid chondrosarcoma. Long-term experience with chemotherapy.
    Patel SR; Burgess MA; Papadopoulos NE; Linke KA; Benjamin RS
    Am J Clin Oncol; 1995 Apr; 18(2):161-3. PubMed ID: 7900708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis.
    Niemeijer ND; Alblas G; van Hulsteijn LT; Dekkers OM; Corssmit EP
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):642-51. PubMed ID: 25041164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.
    Huang H; Abraham J; Hung E; Averbuch S; Merino M; Steinberg SM; Pacak K; Fojo T
    Cancer; 2008 Oct; 113(8):2020-8. PubMed ID: 18780317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy.
    Al-Hader AA; Jain A; Al-Nasrallah N; Einhorn LH
    Am J Clin Oncol; 2015 Aug; 38(4):364-6. PubMed ID: 23799289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy in adult desmoid tumors.
    Patel SR; Evans HL; Benjamin RS
    Cancer; 1993 Dec; 72(11):3244-7. PubMed ID: 8242548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine: a single-center experience.
    Deutschbein T; Matuszczyk A; Moeller LC; Unger N; Yuece A; Lahner H; Mann K; Petersenn S
    Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):540-3. PubMed ID: 21667440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
    J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and outcomes of metastatic pheochromocytoma treated by cytotoxic chemotherapy.
    Fujiwara Y; Ohmoto A; Fukuda N; Wang X; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Yuasa T; Yonese J; Takahashi S
    Endocr J; 2021 Jun; 68(6):671-681. PubMed ID: 33518616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A CASE OF MALIGNANT PARAGANGLIOMA OF THE URINARY BLADDER TREATED WITH CYCLOPHOSPHAMIDE, VINCRISTINE, AND DACARBAZINE CHEMOTHERAPY AND METAIODOBENZYLGUANIDINE THERAPY].
    Yamauchi Y; Matsukawa Y; Kato M; Yoshino Y; Yamamoto T; Kobayashi H; Gotoh M
    Nihon Hinyokika Gakkai Zasshi; 2018; 109(2):106-110. PubMed ID: 31006739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia.
    Cortes J; Thomas D; Rios A; Koller C; O'Brien S; Jeha S; Faderl S; Kantarjian H
    Cancer; 2002 Mar; 94(5):1492-9. PubMed ID: 11920506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.
    Hadoux J; Favier J; Scoazec JY; Leboulleux S; Al Ghuzlan A; Caramella C; Déandreis D; Borget I; Loriot C; Chougnet C; Letouzé E; Young J; Amar L; Bertherat J; Libé R; Dumont F; Deschamps F; Schlumberger M; Gimenez-Roqueplo AP; Baudin E
    Int J Cancer; 2014 Dec; 135(11):2711-20. PubMed ID: 24752622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with cyclophosphamide, vincristine, and dacarbazine in patients with malignant pheochromocytoma and paraganglioma.
    Tanabe A; Naruse M; Nomura K; Tsuiki M; Tsumagari A; Ichihara A
    Horm Cancer; 2013 Apr; 4(2):103-10. PubMed ID: 23361939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CYVADIC regimen as a combination chemotherapy treatment option for advanced soft tissue sarcomas originating from the non-extremities.
    Nakano K; Motoi N; Takahashi S
    Intern Med; 2015; 54(2):187-93. PubMed ID: 25743010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
    Brito RA; Valero V; Buzdar AU; Booser DJ; Ames F; Strom E; Ross M; Theriault RL; Frye D; Kau SW; Asmar L; McNeese M; Singletary SE; Hortobagyi GN
    J Clin Oncol; 2001 Feb; 19(3):628-33. PubMed ID: 11157012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.